Integral to our mission to improve human health, The Jackson Laboratory (JAX) is committed to helping address the coronavirus pandemic as rapidly as possible.
This page is dedicated to providing you with up-to-date information about:
- How JAX is applying our expertise in human genomics and mammalian genetics to help support the quickly evolving public health crisis.
- The steps the Laboratory is taking to ensure the health of our employees, welfare of the mice under our care, and our mission of continuing to advance biomedical research during this difficult time.
Recent News from JAX
-
Tech Corner
February 01, 2021
New coronavirus variants spark concerns
Mutations in SARS-CoV-2 are generating viral variants that change the properties of the virus and affect the response to the COVID-19 pandemic.
-
Press Release
January 26, 2021
Continued public testing urged during vaccine rollout
While Connecticut's vaccine rollout is progressing successfully, with the state ranking fifth nationally for the highest percent of the population vaccinated, continued public testing and caution are still more important than ever.
-
Press Release
December 02, 2020
JAX nominated as a healthcare hero
The Hartford Business Journal has recognized JAX among its 2020 Health Care Heroes in the Innovation category, recognizing an organization that has made a positive advancement in medical care or medical science.
-
Tech Corner
September 25, 2020
Charles Lee appears on CBIA BizCast
Charles Lee spoke on CBIA BizCast about JAX’s work in mitigating COVID-19 including a partnership with Yale to expand the use of a saliva COVID-19 test, the breeding of COVID-19 mouse models, and more.
-
Search Magazine
May 19, 2020
Help for heroes
Coronavirus testing at The Jackson Laboratory helps officials track and prevent transmission of COVID-19. To date, JAX has processed more than one million tests.
-
Research Highlight
August 03, 2020
Unlocking age-dependent coronavirus susceptibility
Genetically varied mouse populations revealing genetic elements contributing to SARS-CoV-2 infection risk.
-
Research Highlight
February 01, 2021
Novel antibody tests reveal complexity of immune response to covid-19
The interaction of SARS-CoV-2, the novel coronavirus causing the global COVID-19 pandemic, and the human immune system has been the focus of intensive research.
-
Featured Article
January 11, 2021
Top tips for overcoming the impact of the pandemic on scientific discovery
With the second wave of active COVID-19 cases upon us, use these tips to stay out ahead of the potential disruption to the discovery process.
-
Featured Article
November 17, 2020
COVID-19 update: Where we are and where we need to be
JAX President and CEO Edison T. Liu, M.D., discussed the basic scientific facts of COVID-19, our journey toward a vaccine, potential long-term effects of the virus, and the post-COVID-19 world.
-
Search Magazine
September 22, 2020
Life-preserver: COVID-19 testing to keep Maine Maritime students safe
As the academic year starts up across the country, The Jackson Laboratory has partnered with a variety of educational institutions, including Maine Maritime Academy, to provide COVID-19 testing for students, faculty and staff.
-
Press Release
August 18, 2020
JAX, Yale to collaborate on broad implementation of new saliva-based COVID-19 test
A saliva-based COVID-19 laboratory diagnostic test developed by researchers at the Yale School of Public Health has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).
-
Research Highlight
July 28, 2020
Novel antibody tests reveal complexity of the immune response to SARS-CoV-2
JAX Professor Derya Unutmaz, M.D., led an effort to develop an assay that determines how well anti-SARS-CoV-2 antibodies are able to neutralize binding with ACE-2, the human receptor for the coronavirus.